Document is current
Any future updates will be listed below
-
Authors
Tebartz van Elst, Ludger https://orcid.org/0000-0002-2274-5447
Fangmeier, Thomas
Schaller, Ulrich Max
Hennig, Oliver
Kieser, Meinhard
Koelkebeck, Katja
Kuepper, Charlotte
Roessner, Veit
Wildgruber, Dirk
Dziobek, Isabel
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DFG TE 280/18-1)
Universitätsklinikum Freiburg
- License Information
-
More Information
Article History
Received: 29 December 2020
Accepted: 18 March 2021
First Online: 8 April 2021
Declarations
:
: The whole study process, the study protocol, and the informed consent was approved from all six ethics committee of the recruiting trial sites. Written informed consent to participate will be obtained from all study participants.Ethics Committee of the Humboldt-Universitaet zu BerlinEthics Committee of the Technische Universitaet DresdenEthics Committee of the Medical Faculty of the University of Duisburg-EssenEthics Committee of the Albert-Ludwigs-University of FreiburgEthics Committee II at the University of Heidelberg for the Medical Faculty of MannheimEthics Committee of the Medical Faculty of the University of Tuebingen
: Not applicable.
: Prof. Dr. I. Dziobek and C. Küpper are involved in the development of the SCOTT&EVA computer-based intervention. Prof. Dr. L. Tebartz van Elst and Dr. T. Fangmeier are involved in the development of the FASTER group-therapy. None of them have financial interests.
